查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606329

脑脊髓液管理设备市场：按产品、年龄层和最终用户 - 全球预测 2025-2030

Cerebrospinal Fluid Management Devices Market by Product (CSF Drainage Systems, CSF Shunts), Age Group (Adult, Geriatric, Pediatric), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年脑脊髓液管理设备市场价值为17.3亿美元，预计到2024年将达到18.3亿美元，复合年增长率为6.05%，到2030年将达到26.1亿美元。

脑脊髓液（CSF）管理设备市场包括旨在管理与脑脊髓液流入和排放相关的疾病的设备，这对于各种医疗状况至关重要，例如水脑症、颅内高压和创伤性脑损伤。这些设备透过调节脑脊髓液的压力和流量，对于维持中枢神经系统的健康非常重要，并且主要应用于神经病学和神经外科，以降低脑损伤的风险，改善患者的治疗效果。最终用途通常是医院、神经外科诊所和专科医疗中心。由于神经系统疾病发生率的上升、世界人口的老化以及对先进治疗方案认识的提高，对脑脊髓液管理设备的需求正在增加。关键的成长要素包括医疗技术的快速进步、医疗保健支出的增加以及旨在提高现有设备性能的研发力度的活性化。新的商机在于整合感测器整合分流系统和远端医疗功能等智慧技术，以提高病患监测和设备效率。然而，市场限制包括设备的高成本、需要熟练的专业人员来操作它们以及与这些设备相关的外科手术可能导致的併发症。此外，严格的法律规范和报销挑战也构成了重大障碍。创新可以专注于开发具有成本效益的微创设备，并透过易于使用的功能来提高患者的依从性。整合个人化医疗方法和人工智慧驱动的预测分析来预防併发症具有巨大的潜力。由于市场是动态的、技术不断创新、竞争激烈，企业需要强调策略联盟与合作，以扩大市场范围、增强技术力。为了实现可持续的业务成长，结合持续的产品创新、患者教育计划和积极的监管合规可以提高市场渗透率并提高品牌信誉。

主要市场统计
基准年[2023] 17.3亿美元
预计年份 [2024] 18.3亿美元
预测年份 [2030] 26.1亿美元
复合年增长率（%） 6.05%

市场动态：快速发展的脑脊髓液管理设备市场的关键市场洞察

供需的动态交互作用正在改变脑脊髓液管理设备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 老年人口增加和生活方式的快速变化
    • 全球神经系统疾病增加
    • 全球医疗保健支出增加
  • 市场限制因素
    • 与使用脑脊髓液分流器相关的高成本和感染风险
  • 市场机会
    • 开发精确检测和调整脑脊髓液排放变化的感测器系统
    • 活性化新型创新分流器的研发力度
  • 市场挑战
    • 与脑脊髓液分流失败或故障相关的风险

波特五力：驾驭脑脊髓液管理设备市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解对脑脊髓液管理设备市场的外部影响

外部宏观环境因素在塑造脑脊髓液管理设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解脑脊髓液管理设备市场的竞争状况

脑脊髓液管理设备市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵脑脊髓液管理装置市场供应商绩效评估

FPNV 定位矩阵是评估脑脊髓液管理设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划脑脊髓液管理设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对脑脊髓液管理设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧和生活方式的快速变化
      • 全球神经系统疾病发生率增加
      • 世界各地的医疗费用增加
    • 抑制因素
      • 与使用脑脊髓液分流器相关的设备成本高且有感染风险
    • 机会
      • 开发感测器系统以准确检测和控制脑脊髓液排放的变化
      • 加强新型创新分流器的研发活动
    • 任务
      • 与脑脊髓液分流失败或故障相关的风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脑脊髓液管理设备市场：依产品

  • 脑脊髓液引流系统
    • 腰椎引流系统
    • 脑室引流系统
  • 脑脊髓液分流术
    • 可调式脑脊髓液分流器
    • 固定式脑脊髓液分流术

第七章脑脊髓液管理设备市场：依年龄组

  • 成人用
  • 老年病
  • 小儿科

第八章脑脊髓液管理设备市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 医院
  • 神经中枢

第九章北美及南美洲脑脊髓液管理设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区脑脊髓液管理设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲脑脊髓液管理设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • B. Braun Melsungen AG
  • BeckerSmith Medical, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biogen Inc.
  • bioMerieux, SA
  • CereVasc, Inc.
  • Delta Surgical Ltd.
  • Enzo Biochem Inc.
  • G. Surgiwear Ltd.
  • Integra LifeSciences Corporation
  • IRRAS AB
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • MOLLER Medical GmbH
  • Natus Medical Incorporated
  • Neuromedex GmbH
  • Penumbra, Inc.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Sinduri Biotec
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
  • Stryker Corporation
  • Terumo Corporation
  • Trivitron Healthcare
  • Wellong Instruments Co., Ltd.
Product Code: MRR-DD0700E81DAC

The Cerebrospinal Fluid Management Devices Market was valued at USD 1.73 billion in 2023, expected to reach USD 1.83 billion in 2024, and is projected to grow at a CAGR of 6.05%, to USD 2.61 billion by 2030.

The cerebrospinal fluid (CSF) management devices market encompasses a range of products designed to manage disorders related to the flow and drainage of cerebrospinal fluid, essential in various medical conditions including hydrocephalus, intracranial hypertension, and traumatic brain injuries. These devices are critical in maintaining CNS health by regulating CSF pressure and flow, with applications primarily in neurology and neurosurgery to mitigate risks of brain damage and enhance patient outcomes. End-use scopes often involve hospitals, neurosurgery clinics, and specialized medical centers. The necessity of CSF management devices is accentuated by the rising incidence of neurological disorders, an aging global population, and growing awareness of advanced treatment options. Key growth factors include the rapid advancements in medical technology, increasing healthcare expenditure, and escalated research and development efforts aimed at improving existing device performance. Emerging opportunities lie in embracing smart technologies, such as sensor-integrated shunt systems and telemedicine capabilities, to enhance patient monitoring and device efficiency. However, market limitations include high costs of devices, the need for skilled professionals for operation, and potential complications arising from surgical procedures related to these devices. Moreover, stringent regulatory frameworks and reimbursement challenges pose significant hurdles. Innovation could focus on developing cost-effective and minimally invasive devices, as well as enhancing patient compliance through ease-of-use features. There's substantial potential in personalized medicine approaches and integrating AI-enabled predictive analytics to preempt complications. The market is dynamic, characterized by constant technological innovations and intensive competition, necessitating companies to focus on strategic partnerships and collaborations to expand market reach and enhance technological capabilities. For sustained business growth, embracing continuous product innovation, patient education programs, and proactive regulatory compliance can facilitate deeper market penetration and improved brand credibility.

KEY MARKET STATISTICS
Base Year [2023] USD 1.73 billion
Estimated Year [2024] USD 1.83 billion
Forecast Year [2030] USD 2.61 billion
CAGR (%) 6.05%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cerebrospinal Fluid Management Devices Market

The Cerebrospinal Fluid Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population and rapidly changing lifestyle
    • Global increase in the incidence of neurological diseases
    • Rising healthcare expenditure across the world
  • Market Restraints
    • High cost of devices and risk of infection with the usage of CSF shunts
  • Market Opportunities
    • Development of sensor systems for accurate detection and regulation of changes in CSF drainage
    • Increasing research and development activities for new and innovative shunts
  • Market Challenges
    • Risks associated with the failure and malfunctioning of CSF shunts

Porter's Five Forces: A Strategic Tool for Navigating the Cerebrospinal Fluid Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cerebrospinal Fluid Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cerebrospinal Fluid Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cerebrospinal Fluid Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cerebrospinal Fluid Management Devices Market

A detailed market share analysis in the Cerebrospinal Fluid Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cerebrospinal Fluid Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cerebrospinal Fluid Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cerebrospinal Fluid Management Devices Market

A strategic analysis of the Cerebrospinal Fluid Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cerebrospinal Fluid Management Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, BeckerSmith Medical, Inc., Bio-Rad Laboratories, Inc., Biogen Inc., bioMerieux, SA, CereVasc, Inc., Delta Surgical Ltd., Enzo Biochem Inc., G. Surgiwear Ltd., Integra LifeSciences Corporation, IRRAS AB, Johnson & Johnson Services, Inc., Medtronic PLC, MOLLER Medical GmbH, Natus Medical Incorporated, Neuromedex GmbH, Penumbra, Inc., Shenzhen New Industries Biomedical Engineering Co., Ltd., Sinduri Biotec, Sophysa SA, Spiegelberg GmbH & Co. KG, Stryker Corporation, Terumo Corporation, Trivitron Healthcare, and Wellong Instruments Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cerebrospinal Fluid Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across CSF Drainage Systems and CSF Shunts. The CSF Drainage Systems is further studied across Lumbar Drainage System and Ventricular Drainage System. The CSF Shunts is further studied across Adjustable CSF Shunts and Fixed CSF Shunts.
  • Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, Hospitals, and Neurological Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population and rapidly changing lifestyle
      • 5.1.1.2. Global increase in the incidence of neurological diseases
      • 5.1.1.3. Rising healthcare expenditure across the world
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of devices and risk of infection with the usage of CSF shunts
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of sensor systems for accurate detection and regulation of changes in CSF drainage
      • 5.1.3.2. Increasing research and development activities for new and innovative shunts
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with the failure and malfunctioning of CSF shunts
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cerebrospinal Fluid Management Devices Market, by Product

  • 6.1. Introduction
  • 6.2. CSF Drainage Systems
    • 6.2.1. Lumbar Drainage System
    • 6.2.2. Ventricular Drainage System
  • 6.3. CSF Shunts
    • 6.3.1. Adjustable CSF Shunts
    • 6.3.2. Fixed CSF Shunts

7. Cerebrospinal Fluid Management Devices Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Geriatric
  • 7.4. Pediatric

8. Cerebrospinal Fluid Management Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Hospitals
  • 8.5. Neurological Centers

9. Americas Cerebrospinal Fluid Management Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cerebrospinal Fluid Management Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cerebrospinal Fluid Management Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. BeckerSmith Medical, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biogen Inc.
  • 5. bioMerieux, SA
  • 6. CereVasc, Inc.
  • 7. Delta Surgical Ltd.
  • 8. Enzo Biochem Inc.
  • 9. G. Surgiwear Ltd.
  • 10. Integra LifeSciences Corporation
  • 11. IRRAS AB
  • 12. Johnson & Johnson Services, Inc.
  • 13. Medtronic PLC
  • 14. MOLLER Medical GmbH
  • 15. Natus Medical Incorporated
  • 16. Neuromedex GmbH
  • 17. Penumbra, Inc.
  • 18. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • 19. Sinduri Biotec
  • 20. Sophysa SA
  • 21. Spiegelberg GmbH & Co. KG
  • 22. Stryker Corporation
  • 23. Terumo Corporation
  • 24. Trivitron Healthcare
  • 25. Wellong Instruments Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY LUMBAR DRAINAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY VENTRICULAR DRAINAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY ADJUSTABLE CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY FIXED CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY NEUROLOGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF DRAINAGE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY CSF SHUNTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023